Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens

Immunogenic formulation of OspC antigen vaccines for the prevention and treatment of lyme disease and recombinant methods for the preparation of such antigens

US Patent 6872550 · Granted Mar 29, 2005

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Surgical headlamp assembly2024
Chimeric OspA genes, proteins and methods of use thereof2022
Chimeric OspA genes, proteins and methods of use thereof2022
Animal protein-free media for cultivation of cells2020
Animal protein-free media for cultivation of cells2018
Recombinant cell clones having increased stability and methods of making and usi2018
Medium for the protein-free and serum-free cultivation of cells2018
Recombinant cell clones having increased stability and methods of making and usi2018
Recombinant cell clones having increased stability and methods of making and usi2018
Chimeric OspA genes, proteins and methods of use thereof2018
Chimeric OspA genes, proteins and methods of use thereof2018
Animal protein-free media for cultivation of cells2017